Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05604001

In-office Hysteroscopic Laser Ablation for Symptomatic Submucous Uterine Fibroids

Conditions: Laser Hysteroscopic Ablation of Submucous Myoma

Sex: Female
Ages: 18 Years – 50 Years
Healthy volunteers: 1
Phase: NA
Enrollment: 20
Sponsor: Ariel University

Location: Spain

Summary

To evaluate feasibility and efficacy of in-office hysteroscopic ablation of submucous uterine fibroid using diode laser

Eligibility Criteria

Inclusion Criteria:symptomatic patients without desire of future fertility (symptoms included heavy menstrual bleeding, abdominal discomfort, bulk symptoms such as urinary frequency, pelvic pressure and constipation),grade 0-2 (FIGO classification) ≤ 7cm fibroids with evident vascularity seen by 3D-DS compared to its adjacent myometrial tissueExclusion Criteria:intramural fibroids (FIGO class 3 or more),>2 submucosal fibroids,pelvic inflammatory disease,known gynecologic malignancy,severe cervical stenosis,pregnancydesire of future fertility,previous cervical surgery

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05604001). StuddyBuddy aggregates publicly available trial information.